CHEMED CORPORATION Accrued Fees and Other Revenue Receivable
CHEMED CORPORATION (CHE) had Accrued Fees and Other Revenue Receivable of $5.56 million as of 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Balance Sheet › Assets
us-gaap:AccruedFeesAndOtherRevenueReceivable · last filed 2018-02-26
- 2017-12-31: Accrued Fees and Other Revenue Receivable $5.56M.
- 2016-12-31: Accrued Fees and Other Revenue Receivable $3.15M.
- 2015-12-31: Accrued Fees and Other Revenue Receivable $1.89M.
| Period end | Accrued Fees and Other Revenue Receivable |
|---|---|
| 2017-12-31 | $5.56M 10-K · filed 2018-02-26 |
| 2016-12-31 | $3.15M 10-K · filed 2018-02-26 |
| 2015-12-31 | $1.89M 10-K · filed 2018-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |